SkyQuest Technology Group recently introduced Plasma Therapy Market study with in-depth overview, describing about the Product/Industry Scope and elaborates market outlook and status (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. The Plasma Therapy Market has witnessed Excellent growth over the past decade and is expected to maintain its upward trajectory.
Global Plasma Therapy Market size was valued at USD 310.0 million in 2023 and is poised to grow from USD 354.33 million in 2024 to USD 1032.23 million by 2032, growing at a CAGR of 14.3% during the forecast period (2025-2032).
White blood cells (WBCs), red blood cells (RBCs), plasma, and platelets are known components of blood. As plasma contains a high concentration of antibodies, it can be utilized in plasma therapy to transmit the immunity of a healthy recovered individual to the patient. This therapy has been used for a very long period, mostly in orthopaedics, dermatology, and dentistry. The rise in androgenic alopecia patients worldwide is one of the key reasons expected to propel the growth of the market during the forecast period.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/plasma-therapy-market
The 2025 global Plasma Therapy Market report provides a comprehensive analysis of key industry players, market trends, pricing structures, and competitive dynamics, offering insights into the market landscape from 2025 to 2032. As a rapidly evolving sector, the Plasma Therapy Market drives economic growth, innovation, and technological advancements through the development, production, and distribution of products and services. This report highlights the market’s growth potential and its impact on global industries, providing valuable insights for stakeholders, investors, and policymakers.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Plasma Therapy Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global Plasma Therapy Market is segmented by Type, Source, Application, End User and region.
Based on Type, the market is segmented into Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin.
Based on Source, the market is segmented into Autologous and Allogenic.
Based on Application, the market is segmented into Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury and Others.
Based on End User, the market is segmented into Hospitals & Clinics and Research Institutes.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Plasma Therapy Market – Regional Analysis:
Due to the existence of top platelet-rich plasma therapy product manufacturers, active involvement of academic and research institutions in trying to cut research and development activities, rising public awareness of the benefits of platelet-rich plasma therapies, and support from regulatory bodies and the government to promote the use of PRP for medical purposes, North America held the largest market share for plasma therapy in 2021. The availability of highly skilled individuals and the region’s well-developed healthcare infrastructure both drive market growth.
The market in Asia Pacific is expected to grow at the fastest CAGR, owing to high population density and the rising prevalence of chronic diseases. Huge market opportunities are being created by the expansion of healthcare facilities and government efforts to enhance public health. A major factor in the expansion of the regional market is the abundance of disease patients in the region. The market in Asia-Pacific is also growing as a result of an increase in investment by the key industry players in the region.
Top Market Players in Plasma Therapy Market are:
CSL Behring (Australia)
Grifols S.A. (Spain)
Kedrion S.p.A. (Italy)
Octapharma AG (Switzerland)
Takeda Pharmaceutical Company Limited (Japan)
Zimmer Biomet (US)
Baxter International Inc. (US)
China Biologic Products Holdings, Inc. (China)
GC Pharma (South Korea)
Green Cross Corp. (South Korea)
Japan Blood Products Organization (Japan)
LFB SA (France)
Shanghai RAAS Blood Products Co., Ltd. (China)
China National Biotec Group Co., Ltd. (CNBG) (China)
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. (China)
Jiangxi Boya Bio-Pharmaceutical Co., Ltd. (China)
Bio Products Laboratory Ltd. (BPL) (UK)
BioLife Plasma Services (US)
Canadian Plasma Resources (Canada)
For a customized report, contact us to request personalization – https://www.skyquestt.com/speak-with-analyst/plasma-therapy-market
Plasma Therapy Market Recent Developments:
In 2021, In order to fulfil the rising demand for plasma-related therapies, BioLife Plasma Services (US) constructed a new plasma centre in Worcester.
In 2021, In the Czech Republic, Biotest AG (Germany) opened its sixth plasma collecting facility. the development of new facilities to guarantee a long-term plasma supply.
Take Action Now: Secure Your Plasma Therapy Market Today – https://www.skyquestt.com/buy-now/plasma-therapy-market
Forward-Looking Insights
The Plasma Therapy Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
